Observational studyEye (London, England)2026
Prognostic value of foveal choroidal vascular hyperpermeability on indocyanine green angiography in central serous chorioretinopathy.
Observational study in Eye (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo assess the association between the foveal location of choroidal vascular hyperpermeability (CVH) on indocyanine green angiography (ICGA) at the first visit and the visual acuity at the end of the follow-up in central serous chorioretinopathy (CSC).
methodsThis retrospective, observational, longitudinal study was conducted in the ophthalmology department of Lariboisière Hospital, Paris, France. Patients with CSC who underwent multimodal imaging, including ICGA, with a follow-up of more than 3 years, were included. The Early Treatment of Diabetic Retinopathy Study (ETDRS) grid was superimposed over mid-phase ICGA images at the first visit to determine CVH location. CVH were classified according to the location of the lesion within the central 3-mm ETDRS circle.
resultsEighty-four eyes of 68 patients with a mean follow-up duration of 6.5 ± 3 years were included. Patients' mean age was 48.3 ± 14.3 years and 59 patients (86.8%) were men. A foveal CVH was identified in 60 eyes (71.4%). The multivariate analysis showed an association between a final visual acuity worse than 0.3 logMAR (20/40 Snellen equivalent) and a lower initial visual acuity (p = 0.001), the presence of gravitational tracts (p = 0.034) and a foveal CVH at the first visit (p = 0.026).
conclusionThis study suggested that the presence of a foveal CVH is associated with a decline in visual acuity over time. Our findings highlighted the importance of performing ICGA at the first visit to assess disease severity and guide the monitoring of CSC patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.